Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Quantitative model for predicting CYP inhibition parameters for novel arylpiperazine derivatives.

2015/17/N/NZ7/04110

Keywords:

QSAR molecular modeling arylpiperazines CYP interactions

Descriptors:

  • NZ7_14: Pharmacy, pharmacotherapy, pharmacology
  • NZ1_2: Biochemistry

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

woj. pomorskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr Szymon Ulenberg 

Number of co-investigators in the project: 2

Call: PRELUDIUM 9 - announced on 2015-03-16

Amount awarded: 149 800 PLN

Project start date (Y-m-d): 2016-03-16

Project end date (Y-m-d): 2019-09-15

Project duration:: 42 months (the same as in the proposal)

Project status: Project settled

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. 3 letnia licencja oprogramowania Accelrys Discovery Studio. (16 000 PLN)

Information in the final report

  • Publication in academic press/journals (2)
  1. Molecular docking supplements an in vitro determination of the leading CYP isoform
    Authors:
    Szymon Ulenberg, Joanna Zielińska, Mariusz Belka, Marek Król, Franciszek Herold, Tomasz Bączek
    Academic press:
    Combinatorial Chemistry & High Throughput Screening (rok: 2019, tom: 22, strony: 370-378), Wydawca: Bentham Science
    Status:
    Published
    DOI:
    10.2174/1386207322666190705143322 - link to the publication
  2. In Vitro approach for identification of a leading cytochrome P450 isoenzyme responsible for biotransformation of novel arylpiperazine drug candidates and their inhibition potency towards CYP3A4.
    Authors:
    Szymon Ulenberg, Mariusz Belka, Paweł Georgiev, Marek Król, Franciszek Herold, Tomasz Bączek
    Academic press:
    Acta Poloniae Pharmacautica Drug Research (rok: 2020, tom: 7, strony: ), Wydawca: Polskie Towarzystwo Farmaceutyczne
    Status:
    Accepted for publication
    DOI:
    brak - link to the publication

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy